// App-Quantinova.ai

P070 : Long-Term Efficacy and Safety of Teriflunomide: An Analysis of Pooled Clinical Trials

Researchers

Presenter

  • Mark Freedman

Principal Investigators

  • Jihad Inshasi

  • Lluis Ramio-Torrenta

  • Mauro Zaffaroni

  • Jerome de Seze

  • Suk-won Ahn

  • Richard Macdonell

  • Aaron Miller

  • Boris Kallmann

  • David Rog

  • Myriam Benamor

  • Philippe Truffinet

  • Jeffrey Chavin

  • Elizabeth Poole

  • Christine Lebrun-Frenay

Medical Centers

  • University of Ottawa, and Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • Dubai Hosp, Dubai, United Arab Emirates

  • Doctor Josep Trueta University Hospital, Girona, Spain

  • Gallarate Hospital, Gallarate VA, Italy

  • University Hospital of Strasbourg, Strasbourg, France

  • Soonchunhyang University, College of Medicine, Cheonan, Korea, Republic of (South)

  • Florey Institute of Neuroscience and Mental Health, Parkville, Australia

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • Neurologische Praxis und multiple sklerose zentrum bamberg (mszb) im alphaMED, Bamberg, Germany

  • 2Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust Salford United Kingdom

  • Sanofi, Chilly-Mazarin, France

  • Sanofi, Cambridge, MA

  • Universite Cote dAzur, Nice, France

Locations

  • Canada

  • United Arab Emirates

  • Spain

  • Italy

  • France

  • Republic of South Korea

  • Australia

  • United States

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Teriflunomide

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • III

Study Id's

  • NCT01487096

  • NCT00803049]

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved